{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:05:17Z","timestamp":1776287117319,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.suronc.2023.102016","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T11:49:25Z","timestamp":1700826565000},"page":"102016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-3417","authenticated-orcid":false,"given":"Elena","family":"Leinert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Lukac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Schwentner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visnja","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Veselinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davut","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Janni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.P.","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suronc.2023.102016_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-016-4016-4","article-title":"Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade","volume":"160","author":"Hennigs","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.suronc.2023.102016_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1055\/a-0646-4630","article-title":"Guideline of the DGGG and the DKG (S3-level, AWMF registry number 032\/045ol, december 2017) \u2013 Part 2 with recommendations for the therapy of primary, recurrent and advanced breast cancer","volume":"78","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"2","key":"10.1016\/j.suronc.2023.102016_bib4","first-page":"69e77","article-title":"Staging the axilla in women with breast cancer: the utility of preoperative ultrasound-guided needle biopsy","volume":"11","author":"Houssami","year":"2014","journal-title":"Cancer Biol Med"},{"issue":"14","key":"10.1016\/j.suronc.2023.102016_bib5","doi-asserted-by":"crossref","first-page":"1455e61","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.suronc.2023.102016_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and metaanalysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2023.102016_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2023.102016_bib8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2023.102016_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg."},{"issue":"8","key":"10.1016\/j.suronc.2023.102016_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg."},{"issue":"4","key":"10.1016\/j.suronc.2023.102016_bib11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.suronc.2023.102016_bib12","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2 positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2023.102016_bib13","unstructured":"Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM. Axillary staging of breast cancer: what the radiologist should know. Radiogr. Rev. Publ. Radiol.."},{"issue":"7","key":"10.1016\/j.suronc.2023.102016_bib14","doi-asserted-by":"crossref","first-page":"609e18","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinellymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"issue":"15","key":"10.1016\/j.suronc.2023.102016_bib15","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtype1s","volume":"30","author":"Von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2023.102016_bib16","article-title":"Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","author":"Reimer","year":"2022","journal-title":"EClin. Med."},{"issue":"4","key":"10.1016\/j.suronc.2023.102016_bib17","article-title":"Axillary dissection in node-positive breast cancer: a retrospective study and cost analysis","volume":"13","author":"Beniey","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.suronc.2023.102016_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.breast.2016.11.012","article-title":"Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - results from the multi-center SENTINA trial","volume":"31","author":"Schwentner","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.suronc.2023.102016_bib19","doi-asserted-by":"crossref","unstructured":"Schipper, R.J., Moossdorff M, Beets-Tan R.G.H. et al. Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review. Eur. J. Radiol., Volume 84 , Issue 1 , 41 \u2013 47.","DOI":"10.1016\/j.ejrad.2014.09.020"},{"key":"10.1016\/j.suronc.2023.102016_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0019-509X.12339","article-title":"Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla?","volume":"41","author":"Arimappamagan","year":"2004","journal-title":"Indian J. Cancer"},{"issue":"22","key":"10.1016\/j.suronc.2023.102016_bib21","doi-asserted-by":"crossref","first-page":"36696","DOI":"10.18632\/oncotarget.13313","article-title":"Accuracy of axillary ultrasound after different neoadjuvant chemotherapy cycles in breast cancer patients","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.suronc.2023.102016_bib22","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2023.102016_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","article-title":"The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT)","volume":"35","author":"Peppe","year":"2017","journal-title":"Breast"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740423001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740423001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:22:48Z","timestamp":1760757768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740423001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":22,"alternative-id":["S0960740423001160"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2023.102016","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of axillary ultrasound (AUS) to assess the nodal status after neoadjuvant chemotherapy (NACT) in primary breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2023.102016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102016"}}